Medtronic Inc


  • Health Industry CEOs: More Confidence, Challenges Tuesday, 10 Jan 2012 | 3:12 PM ET

    Chief executives at some of the biggest U.S. biotech and pharmaceutical companies are at the annual JPMorgan health care conference in San Francisco. Here's what some of them told  CNBC on Tuesday.

  • Medical Device Titans on Obamacare     Tuesday, 10 Jan 2012 | 2:16 PM ET

    Discussing how Obamacare's new 2.3% tax on the biggest medical device makers is impacting business, with Omar Ishrak, Medtronic CEO; Michael Mussallem, Edwards Lifesciences CEO; and Stephen MacMillan, Stryker Corporation CEO.

  • Farr: My Top Ten Stocks for 2012 Friday, 30 Dec 2011 | 10:48 AM ET

    CNBC contributor Michael Farr offers his ten stock picks for 2012.

  • Medtronic Won't Spin Off Units, Cut Sales Force: CEO Tuesday, 22 Nov 2011 | 12:40 PM ET
    Medtronic Maximo DR implantable cardioverter-defibrillator

    Despite calls from some of its investors, Medtronic won't be spinning off any more business units, Chief Executive Omar Ishrak told CNBC Tuesday.

  • Medtronic Reports Q2 Results     Tuesday, 22 Nov 2011 | 11:45 AM ET

    Medtronic's profits rose in the second quarter, beating Wall Street estimates. Omar Ishrak, CEO of Medtronic, weighs in.

  • Voting to Hire a Chief Without Meeting Him Thursday, 22 Sep 2011 | 10:27 AM ET
    Leo Apotheker

    The mystery isn’t why Hewlett-Packard is likely to part ways with its chief executive, Léo Apotheker, after just a year in the job. It’s why he was hired in the first place. The New York Times reports.

  • Dow Soars 300, Logs Biggest Gain in 2 Weeks Tuesday, 23 Aug 2011 | 4:31 PM ET
    Streets of NYC after the earthquake on Auguat

    Stocks closed near session highs Tuesday, with the Dow posting its biggest gain in almost two weeks, despite a 5.8-magnitude earthquake in Virginia that shook parts of the U.S. East Coast and after investors shrugged off a handful of disappointing economic news.

  • Futures Gain, Helped by Global Markets Tuesday, 23 Aug 2011 | 9:09 AM ET

    Futures were higher Tuesday, boosted by better-than-expected manufacturing data in Germany and China, and ahead of a handful of reprots in the U.S.

  • Some Health-Care Stocks Still Worth Buying: Analysts Thursday, 11 Aug 2011 | 12:53 PM ET
  • Stocks Close Lower After Choppy Session Tuesday, 24 May 2011 | 4:56 PM ET

    Stocks ended modestly lower amid further signs of economic weakness, and despite a positive call on commodities by Goldman Sachs, which lifted prices of oil and metals.

  • Stocks Turn Lower Before Close; Energy Gains Tuesday, 24 May 2011 | 3:57 PM ET

    Stocks turned modestly lower before the close amid more news of weakness in the nation's manufacturing sector, and a positive call on commodities by Goldman Sachs lifted prices of oil and metals.

  • Stocks Trade Mixed; Energy Rises, Banks Fall Tuesday, 24 May 2011 | 11:53 AM ET

    Stocks turned mixed a day after a steep selloff, although energy and materials sectors were lifted by a positive report on commodities prices by Goldman Sachs.

  • Futures Gain Slightly as Euro Debt Fears Linger Tuesday, 24 May 2011 | 9:23 AM ET

    Stock index futures gained ahead of the open Tuesday, tracking European and Asian shares higher a day after the markets sold off amid fears over euro zone debt troubles and falling commodity prices.

  • 'There's No Place to Put Any Money' Tuesday, 24 May 2011 | 9:05 AM ET

    "There's no place to put any money," one trader lamented to me this morning, arguing why he thought the market had a good chance of rising even through the QE2 uncertainty.

  • Medtronic Profit Drops on Job-Cutting Expenses Tuesday, 24 May 2011 | 7:47 AM ET

    Medtronic, the world's largest medical device maker, says its fourth-quarter net income dropped 19 percent on expenses related to its recent layoffs.

  • What Cramer's Watching Next Week Friday, 20 May 2011 | 6:25 PM ET

    The "Mad Money" host reveals what he plans to watch in the days to come.

  • Throw Back The Big Ones Friday, 20 May 2011 | 2:47 PM ET
    Cost of healthcare

    Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector: large-cap pharmaceutical stocks.

  • Cramer makes the call on viewers' favorite stocks.

  • Stand clear—if the S&P 500 is up only 2 percent over the past five years, the stocks of a number of popular, big companies have flatlined. Cisco may be the most famous, but it’s hardly alone.

  • Cramer makes the call on viewers' favorite stocks.